Brandywine Oak Private Wealth LLC Amicus Therapeutics, Inc. Transaction History

Brandywine Oak Private Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 06, 2020	SELL	$6.63 - $11.16 $97,301 - $163,784	-14,676 Closed	0 $0
Q4 2019 Jan 28, 2020	BUY	$7.48 - $10.75 $109,776 - $157,767	14,676 New	14,676 $142,000
Q1 2019 May 09, 2019	SELL	$10.04 - $13.92 $113,492 - $157,351	-11,304 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$8.38 - $13.44 $94,727 - $151,925	11,304 New	11,304 $110,000

323

323M

1.09M

1.04M

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.66B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Brandywine Oak Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Brandywine Oak Private Wealth LLC with notifications on news.